Creutzfeldt-Jakob Disease: The Problem of Recipient Notification

Journal of Law, Medicine and Ethics 25 (1):34-41 (1997)
  Copy   BIBTEX

Abstract

In the past twelve to eighteen months, another perceived threat to the safety of America's blood supply has arisen. The fear is that Creutzfeldt-Jakob disease will join hepatitis, HW and AIDS in the public and medical consciousness as the 1990s next infectious disease epidemic. A particular kind of ethical dilemma has arisen causing much debate and consternation for hospitals, regulators, and blood suppliers, and has elicited a remarkably varied response.CJD is a rare but uniformly fatal neurological disease: it affects the brain and the rest of the central nervous system. Its incidence in the population of the developed world is about one per million per year, although some geographic anomalies exist. CJD manifests itself in two broad ways. First, the disease is associated with symptoms of mental deterioration and dementia, including memory loss, anxiety, and cognitive impairment. Second, CJD is also associated with a range of neurological symptoms, including muscle rigidity, seizures, tremors, muscle twitching, and spasticity, as well as problems with muscle coordination and unsteady gait, sometimes resulting in total disability.

Other Versions

No versions found

Links

PhilArchive

    This entry is not archived by us. If you are the author and have permission from the publisher, we recommend that you archive it. Many publishers automatically grant permission to authors to archive pre-prints. By uploading a copy of your work, you will enable us to better index it, making it easier to find.

    Upload a copy of this work     Papers currently archived: 102,161

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Creutzfeldt-Jakob Disease: The Problem of Recipient Notification.Gordon DuVal - 1997 - Journal of Law, Medicine and Ethics 25 (1):34-41.
Ethical considerations in presymptomatic testing for variant CJD.R. E. Duncan - 2005 - Journal of Medical Ethics 31 (11):625-630.
Parkinsonian Rigidity: The First Hundred-and-One Years 1817-1918.Francis Schiller - 1986 - History and Philosophy of the Life Sciences 8 (2):221 - 236.
Ebola, epidemics, and ethics - what we have learned.G. Kevin Donovan - 2014 - Philosophy, Ethics, and Humanities in Medicine 9:15.

Analytics

Added to PP
2010-08-31

Downloads
46 (#494,865)

6 months
6 (#757,679)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references